Cynthia Collins - 23 Jul 2021 Form 4 Insider Report for Poseida Therapeutics, Inc.

Role
Director
Signature
/s/ Harry J. Leonhardt, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
23 Jul 2021
Net transactions value
$0
Form type
4
Filing time
26 Jul 2021, 20:29:21 UTC
Previous filing
28 May 2021
Next filing
02 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PSTX Stock Option (Right to Buy) Award $0 +87,440 $0.000000 87,440 23 Jul 2021 Common Stock 87,440 $8.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest and become exercisable in 36 equal monthly installments following the grant date set forth in column 3 above.